Introduction: Spontaneous intracerebral hemorrhage (sICH) accounts for 10–15% of all strokes and is characterized by a 30–50% 3-month mortality rate. Intraventricular hemorrhage (IVH) extension can be seen in up to 54% of spontaneous intracerebral hemorrhage and is an independent predictor of worse outcome and neurological deterioration. Objective: To predict outcome and prognosis in spontaneous intracerebral hemorrhage patient in relation with intraventricular hemorrhage extension. Materials and Methods: Hospital based prospective study carried out in two hundred hemorrhagic stroke patients. The severity of intraventricular hemorrhage extension was calculated using the Graeb scale and volume of hemorrhage was measured by ABC/2 formula using CT scan. Results: Mean age of patients of hemorrhagic stroke was 61.64 ± 12.76 years. 66% of patients were male. Mortality rate of hemorrhagic stroke after the age of 60 years was 47.92% in 1st month. 79.80% of patients were died with GCS score less than 8. In our study 96.08% of patient died with >50 ml Hemorrhage group, on the other hand mortality rate was 48% in 30-50ml hemorrhage group and 11.12% in <30ml hemorrhage group. Mortality rate was 61.17% in hemorrhagic stroke with ventricular extension group on the other hand mortality was 21.65% in hemorrhagic stroke without ventricular extension. Those patients with GRAEB score >5 their mortality rate was 75.00% on the other hand mortality was 49.10% in GRAEB score 1-4. Conclusion: Intraventricular hemorrhage extension increased mortality in spontaneous intracerebral hemorrhage. Increased IVH extension severity, defined by a GRAEB score _5, is an independent predictor of poor outcome of Spontaneous intracerebral hemorrhage alone with age, GCS and hemorrhage volume. Medicine Today 2023 Vol.35(1): 34-39
Background: After decompressive craniectomy for acute brain swelling, bone flaps need to be stored in a sterile fashion until cranioplasty. We can preserve autologous bone flap as a freeze-preserved state or within abdominal subcutaneous tissue. The aim of this study is to compare the cryopreservation with subcutaneous abdominal preservation regarding the effectiveness and safety. Methods:This is an interventional study. The clinical data of 40 patients underwent decompressive craniectomy and subsequent cranioplasty with autologous bone flaps in Neurosurgery Department of Shaheed Shiek Abu Naser Specialized Hospital and others private Medical Colleges in Khulna from Jan 2018 –December2019.20 patients under cranioplasty using autologous bone stored in ultra low freezer.. Another 20 patients cranioplasty with bone flap preserved in subcutaneous abdominal pocket. The analysis included the rate of complications, bone resorption, and reoperation to compare between SP group and CP group. Results: The mean age was found 35.10(±13.34) years in subcutaneous preserved group and 39.90(±16.40) years in cryopreservation group with male predominance was observed in both groups.The rate of complications occurred in 4 (20%) in the SP group and3 (15%) in the CP group( P =0.677). The rate of bone resorption in SP group was 5.0% and CP group was15.0% (P=0.292). Reoperation in subcutaneous preservation group was 2(10.0%) and in cryopreservation group was 3(15%). The difference was not statistically significant between two groups (p = 0.633). Conclusion: SP and CP both might be effective and safe methods for the storage of bone flaps for cranioplasty. There were no significant difference in complications, bone resorption , reoperation among two groups. However, identifying of the method that gives better results might depend on the individual surgeons preference and available equipment. Bang. J Neurosurgery 2021; 10(2): 201-205
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.